Medtronic won FDA approval and is releasing its Deep Brain Stimulation (DBS) Clinician Programmer and Activa Programming Application. The app, loaded on a Samsung Galaxy Tab S2 tablet, lets neurologists and neurosurgeons program the stimulation using intuitive controls.
One significant feature of the new programming capability is that it will allow rechargeable neurostimulators to work up to fifteen years, compared to the current nine year average lifespan. This will cut down on replacement surgeries, lowering the overall cost of the therapy and causing less discomfort for patients.
“After using the Medtronic Clinician Programmer for the first time, I am impressed with the thoughtfulness put into the user interface,” in a statement said Dr. Mohammad Maarouf, associate professor, head of the Department of Stereotaxy and Functional Neurosurgery, Cologne Merheim Medical Center, University of Witten/Herdecke, Germany. “Its intuitive, visual interface and task-based workflow makes daily use easier, saving me time to focus on what’s most important-my patients.”
Here’s a Medtronic video promoting the Clinician Programmer: